remdesivir | WITF

October 12, 2020 | 4:58 PM

Pennsylvania treasurer leads calls to lower price of remdesivir

Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.

By An-Li Herring/WESA

October 8, 2020 | 10:11 AM

In April the National Institutes of Health abruptly terminated funding for the China bat research project with no clear explanation.

By Nurith Aizenman/NPR

August 19, 2020 | 5:08 PM

Doctors around the country say they still don’t fully understand HHS’s system for distributing the drug.

By Sydney Lupkin/NPR

May 14, 2020 | 6:37 AM

By Alan Yu/WHYY